CASI Pharma Signs Up CR Guokang Pharma to Distribute Evomela in China

Life Science

Siemens Overtakes Huawei as Biggest Patent Applicant in Europe

Technology

ZTE Corp Controlling Shareholder Plans 3 Percent Stake Sale After Stock Rebound

Technology

Regeneron/Sanofi wins U.S. approval for expanded use of skin drug

Life Science

BGI Genomics Pays $50 Million for China Rights to Natera Cancer Test

Life Science

Tencent, Tiger Global Lead USD57.9 Million Fundraising for E-Signature Services Firm Fadada

Technology

China regulator approves 95 new video games, including from Tencent, NetEase

Technology

China Finalizes IPO Listing Rules for Shanghai High-Tech Board

Life Science

China Unicom, Telefonica Partner on 5G Networks

Technology

Shanghai Henlius’ Rituxan Biosimilar is First Biosimilar Approved in China

Life Science

China’s Lenovo Sets Up JV With US Cloud Firm NetApp

Technology

Novartis gene therapy would be cost effective up to $900,000 -U.S. group

Life Science

NetEase Kaola, Amazon China’s Cross-Border Portal to Merge in Likely Stock-Swap

Technology

Novo Nordisk Snags FDA Approval for Hemophilia A Treatment

Life Science

Suzhou’s CStone Pharma Schedules $304 Million Hong Kong IPO for Next Week

Life Science